Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Viral Hepatitis

• Publication date

  2006-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2893.2005.00651.xPMID 16364080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical course of acute hepatitis C and changes in HCV markers

  2005cited by this paper
• Clearance of hepatitis C virus after newly acquired infection in injection drug users.

  2004cited by this paper
• Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load

  2003cited by this paper
• Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001.

  2003cited by this paper
• Natural history of chronic hepatitis C

  2002cited by this paper
• Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies

  2002cited by this paper
• Incident hepatitis C virus infection in a community‐based population in Japan

  2002cited by this paper
• Acute hepatitis C virus (HCV) infection in chronic carriers of hepatitis B virus (HBV): the impact of underlying active HBV replication on persistence of HCV infection and antibody responses to HCV

  2002cited by this paper
• Natural history of chronic hepatitis C

  2002cited by this paper
• Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response.

  2001cited by this paper
• Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection

  2001cited by this paper
• Comparison of clinical, virologic and pathologic features in patients with acute hepatitis B and C

  2001cited by this paper
• Hepatitis C viral genotype influences the clinical outcome of patients with acute posttransfusion hepatitis C

  2001cited by this paper
• Epidemiological characteristics, risk factors, and clinical manifestations of acute non‐A–E hepatitis

  2001cited by this paper
• Sequence evolution and cross‐reactive antibody responses to hypervariable region 1 in acute hepatitis C virus infection *

  2001cited by this paper
• Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment

  2001cited by this paper
• Assessment of Long‐Term Outcomes of Community‐Acquired Hepatitis C Infection in a Cohort With Sera Stored From 1971 to 1975

  2000cited by this paper
• Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance.

  2000cited by this paper
• The natural history of hepatitis C virus infection: host, viral, and environmental factors.

  2000cited by this paper
• Natural history of hepatitis C: Its impact on clinical management

  2000cited by this paper
• Low frequency of cirrhosis in a hepatitis C (genotype 1b) single‐source outbreak in germany: A 20‐year multicenter study

  2000cited by this paper
• VIRAL HEPATITIS, LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA Hepatitis C virus clearance is prominent in women in an endemic area

  2000cited by this paper
• Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends

  2000cited by this paper
• GBV‐C/hepatitis G virus in acute nonA–E hepatitis and in acute hepatitis of defined aetiology in Italy

  2000cited by this paper
• Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.

  2000cited by this paper
• Acute Hepatitis C Virus Structural Gene Sequences as Predictors of Persistent Viremia: Hypervariable Region 1 as a Decoy

  1999cited by this paper
• Role of the specific T‐cell response for clearance and control of hepatitis C virus

  1999cited by this paper
• Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin.

  1999cited by this paper
• Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C.

  1999cited by this paper
• Persistence of viremia and the importance of long‐term follow‐up after acute hepatitis C infection

  1999cited by this paper
• Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.

  1999cited by this paper
• Acute sporadic non‐A, non‐B hepatitis in Northeastern Brazil: Etiology and natural history

  1999cited by this paper
• Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research.

  1999cited by this paper
• Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine development

  1999cited by this paper
• Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin.

  1999cited by this paper
• Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.

  1999cited by this paper
• Age-related response to interferon alfa treatment in women vs men with chronic hepatitis C virus infection.

  1998cited by this paper
• Acute hepatitis C among renal failure patients on chronic haemodialysis

  1998cited by this paper
• Correlation between virus genotype and chronicity rate in acute hepatitis C.

  1998cited by this paper
• Recurrence of hepatitis C virus after loss of virus specific CD4+ T cell response in acute hepatitis C

  1998cited by this paper
• Hepatitis C in asymptomatic blood donors

  1997cited by this paper
• Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C

  1997cited by this paper
• Detection of type 2‐like T‐helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity

  1997cited by this paper
• Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection

  1997cited by this paper
• The incidence and risk factors of community‐acquired hepatitis C in a cohort of Italian blood donors

  1997cited by this paper
• Higher elimination rate of hepatitis C virus among women

  1996cited by this paper
• Hepatitis C virus RNA in peripheral blood mononuclear cells: Comparing acute and chronic hepatitis C virus infection

  1996cited by this paper
• Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.

  1996cited by this paper
• Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection.

  1995cited by this paper
• Intrahepatic cholestasis of pregnancy

  1995cited by this paper
• Persistent hepatitis C viremia after acute self‐limiting posttransfusion hepatitis C

  1995cited by this paper
• Antibodies and viremia in acute post‐transfusion hepatitis C: A prospective study

  1994cited by this paper
• Serial quantitative analysis of serum hepatitis C virus RNA level in patients with acute and chronic hepatitis C.

  1994cited by this paper
• Patterns and prevalence of hepatitis C virus infection in posttransfusion non-A, non-B hepatitis.

  1993cited by this paper
• Prevalence of anti‐HCV and HCV viremia in hemodialysis patients in Taiwan

  1992cited by this paper
• Posttransfusion hepatitis revisited by hepatitis C antibody assays and polymerase chain reaction.

  1992cited by this paper
• Hepatitis C virus antibodies and hepatitis C virus RNA in Chinese blood donors determined by ELISA, recombinant immunoblot assay and polymerase chain reaction

  1992cited by this paper
• Use of aminotransferase, hepatitis C antibody, and hepatitis C polymerase chain reaction RNA assays to establish the diagnosis of hepatitis C virus infection in a diagnostic virology laboratory

  1992cited by this paper
• A long-term study of hepatitis C virus replication in non-A, non-B hepatitis.

  1991cited by this paper
• Resolution of acute hepatitis C after therapy with natural beta interferon.

  1991cited by this paper
• The diagnostic virology laboratory.

  1968cited by this paper

• Sex Hormones and the Liver: Implications for Disease Progression and Hormonal Therapy

  2026cites this paper
• Estimated hepatitis C prevalence and viral clearance using residual sera from a large commercial laboratory-November 2023-September 2024.

  2026cites this paper
• Structural repertoire of HCV broadly neutralizing antibodies targeting the E2 front layer supersite.

  2026cites this paper
• Potential Cost-Effectiveness of Machine Learning-Enabled Primary Care Identification of Hepatitis C Virus Patients in the US

  2026cites this paper
• Update on the global burden of acute viral hepatitis in 2021: addressing health inequalities

  2025cites this paper
• Estimated number of people infected with hepatitis B and C virus in Germany in 2013: a baseline prevalence estimate using the workbook method

  2025cites this paper
• Rapid hepatitis C virus replication machinery removal after antiviral treatment with DAA monitored by multimodal imaging.

  2025cites this paper
• Characteristics of an antibody profile associated with protection against hepatitis C virus reinfection in a high-risk cohort

  2025cites this paper
• Notification of blood donors who test positive for transfusion‐transmissible infections

  2025cites this paper
• An 11-year retrospective study on hepatitis C in Saudi Arabia: Seroconversion, recovery rates, and viral genotype distribution.

  2025cites this paper
• Detection of anti-HCV antibodies in the clinical classification and epidemiological surveillance of HCV infection

  2025cites this paper
• Cryo-EM structures of HCV E2 glycoprotein bound to neutralizing and non-neutralizing antibodies determined using bivalent Fabs as fiducial markers

  2025cites this paper
• Temporal dynamics of viral fitness and the adaptive immune response in HCV infection

  2025cites this paper
• Prevalence and Risk Factors of Occult HCV Infection in the Adult Population of Mexico City

  2025cites this paper
• Identity by descent and local ancestry mapping of HCV spontaneous clearance in populations of diverse ancestries

  2025cites this paper
• Hepar-C: A cross-sectional study investigating general population knowledge, attitudes, and behaviors regarding hepatitis C screening in the Latium Region, Italy, October 2022 to May 2023.

  2025cites this paper
• Hepatitis C transmission and progression among people who have injected drugs in Singapore: Modelling treatment for eradication

  2025cites this paper
• Structural Repertoire of HCV Broadly Neutralizing Antibodies Targeting the E2 Front Layer Supersite

  2025cites this paper
• Building a Low-Threshold Model for HCV Diagnosis and Treatment Among Formerly Incarcerated Patients in Alabama

  2025cites this paper
• Is Hepatitis C Virus Infection Common in Pediatric Patients with Persistent and Chronic Immune Thrombocytopenia?

  2024cites this paper
• Modeling the impact of the COVID-19 pandemic on achieving HCV elimination amongst young and unstably housed people who inject drugs in San Francisco

  2024cites this paper
• Is San Diego California on Track to Reach HCV Elimination? A Modeling Analysis of Combination Prevention Strategies

  2024cites this paper
• Hepatitis C virus infection and co-infection with HIV among persons who inject drugs in 10 U.S. cities-National HIV Behavioral Surveillance, 2018.

  2024cites this paper
• Development of an effective single-chain variable fragment recognizing a novel epitope in the hepatitis C virus E2 protein that restricts virus entry into hepatocytes

  2024cites this paper
• Monitoring Progress Towards the Elimination of Hepatitis C as a Public Health Threat in Norway: A Modelling Study Among People Who Inject Drugs and Immigrants

  2024cites this paper
• Hepatitis C virus subtype diversity and transmission clusters characteristics among drug users in Zhuhai, South China

  2024influential citation
• Effectiveness of Direct Antiviral Agents in People with HCV-Monoinfection Compared to HCV/HIV Coinfection in a Real Life Setting

  2024cites this paper
• Potential impact of curative and preventive interventions toward hepatitis C elimination in people who inject drugs-A network modeling study.

  2024cites this paper
• Computational Study on the Wealth Conformations of Hepatitis C Virus Envelope Glycoprotein 2 and Role of Its Glycan Coat

  2024cites this paper
• Effects of N-acetylcysteine on hepatocellular carcinoma in chronic hepatitis C.

  2024cites this paper
• Hepatitis C virus reinfection incidence among gay and bisexual men with HIV in Australia from 2016 to 2020

  2024cites this paper
• Prevalence of chronic hepatitis C infection in the general population: results from a national survey, Romania, 2020 to 2023

  2024cites this paper
• Epidemiology of Hepatitis C over 28 years of monitoring Canadian blood donors: Insight into a low-risk undiagnosed population

  2024cites this paper
• Modeling the impact of a supervised consumption site on HIV and HCV transmission among people who inject drugs in three counties in California, USA.

  2024cites this paper
• Results from a retrospective case finding and re-engagement exercise for people previously diagnosed with hepatitis C virus to increase uptake of directly acting antiviral treatment

  2024cites this paper
• Like a Rolling Stone? A Review on Spontaneous Clearance of Hepatitis C Virus Infection

  2024cites this paper
• Assessment of Gene Expression of Some Human Cluster of Differentiation in Chronic HCV Patients

  2024cites this paper
• Impact and cost-effectiveness of scaling up HCV testing and treatment strategies for achieving HCV elimination among people who inject drugs in England: a mathematical modelling study

  2024cites this paper
• Comparison of anti-HCV combined with HCVcAg (Elecsys HCV Duo immunoassay) and anti-HCV rapid test followed by HCV RNA analysis using qRT-PCR to identify active infection for treatment

  2024cites this paper
• Modeling of randomized hepatitis C vaccine trials: Bridging the gap between controlled human infection models and real-word testing.

  2024cites this paper
• Economic Analysis of National Program for Hepatitis C Elimination, Israel, 2023

  2024cites this paper
• High false hepatitis C antibody positivity rate in a regionally-inclusive population of non-renumerated blood donors in Uganda

  2024cites this paper
• Impact of Transmission Dynamics and Treatment Uptake, Frequency and Timing on the Cost-effectiveness of Directly Acting Antivirals for Hepatitis C Virus Infection

  2024cites this paper
• HCV RNA positivity among hepatitis C patients in Chongqing, China from 2004 to 2021: a cross-sectional study

  2024cites this paper
• Concerted synergy between viral-specific IgG and CD8+ T cells is critical for clearance of an HCV-related rodent hepacivirus

  2024cites this paper
• Biomarkers in Detection of Hepatitis C Virus Infection

  2024cites this paper
• Modelling the impact and cost‐effectiveness of non‐governmental organizations on HIV and HCV transmission among people who inject drugs in Ukraine

  2023cites this paper
• Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination

  2023cites this paper
• Neutralizing antibodies evolve to exploit vulnerable sites in the HCV envelope glycoprotein E2 and mediate spontaneous clearance of infection.

  2023cites this paper
• Prevalence of and Risk Factors for Hepatitis C Virus Infection in World Trade Center Responders

  2023cites this paper
• Modelling hepatitis C infection acquired from blood transfusions in the UK between 1970 and 1991 for the Infected Blood Inquiry

  2023cites this paper
• Current Hepatitis C Vaccine Candidates Based on the Induction of Neutralizing Antibodies

  2023cites this paper
• Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway: A registry-based study.

  2023cites this paper
• Substantial impact of the COVID-19 pandemic on the reported number of diagnosed chronic hepatitis C virus infections in the Netherlands, 2019–2021

  2023cites this paper
• Distribution of Genotypes of Hepatitis C Virus Studied in a Tertiary Care Hospital in Uttarakhand, India: A Retrospective Study

  2023cites this paper
• Single Chain Fragment Variable (scFv) corresponding to a novel epitope within HCV envelope protein restricts virus entry into hepatocytes

  2023cites this paper
• Estimating the impact of a police education program on hepatitis C virus (HCV) transmission and disease burden among PWID in Tijuana, Mexico: A dynamic modeling analysis.

  2023cites this paper
• Convergent antibody responses are associated with broad neutralization of hepatitis C virus

  2023cites this paper
• Impact of HCV Testing and Treatment on HCV Transmission Among Men Who Have Sex With Men and Who Inject Drugs in San Francisco: A Modelling Analysis

  2023cites this paper
• Prevalence of chronic HCV infection in EU/EEA countries in 2019 using multiparameter evidence synthesis

  2023cites this paper
• Cytokine profile and viral diversity in the early seronegative stage of community-acquired hepatitis C virus (HCV) infection

  2023cites this paper
• Acute hepatitis C virus infection: clinical update and remaining challenges

  2023cites this paper
• Hepatitis C Virus Micro-elimination Among People With HIV in San Diego: Are We on Track?

  2023cites this paper
• Immediate treatment for recent hepatitis C infection in people with high-risk behaviors: a systematic review and meta-analysis

  2023cites this paper
• ASPARTATE PLATELET RATIO INDEX AS A PREDICTOR OF SEVERITY OF FIBROSIS IN CHRONIC HEPATITS C

  2023cites this paper
• Hepatitis C and Thalassemia: A Story with (Almost) a Happy Ending

  2023cites this paper
• Identity by descent mapping of HCV spontaneous clearance in populations of diverse ancestry

  2023cites this paper
• Hepatitis C prevalence and key population size estimate updates in San Francisco: 2015 to 2019

  2022influential citation
• Repeated exposure to heterologous hepatitis C viruses associates with enhanced neutralizing antibody breadth and potency

  2022cites this paper
• Qualitative analysis of the barriers and facilitators influencing uptake of direct-acting antiviral therapy for hepatitis C in a primary healthcare environment.

  2022cites this paper
• The HCV Envelope Glycoprotein Down-Modulates NF-κB Signalling and Associates With Stimulation of the Host Endoplasmic Reticulum Stress Pathway

  2022cites this paper
• Feasibility of Hepatitis C Elimination in China: From Epidemiology, Natural History, and Intervention Perspectives

  2022cites this paper
• Modeling the spread of hepatitis C virus amongst people who inject drugs

  2022cites this paper
• High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor

  2022cites this paper
• The contribution of unstable housing to HIV and hepatitis C virus transmission among people who inject drugs globally, regionally, and at country level: a modelling study

  2022cites this paper
• Uncovering Resistance to Hepatitis C Virus Infection: Scientific Contributions and Unanswered Questions in the Irish Anti-D Cohort

  2022cites this paper
• Prevalence of hepatitis C virus infection among men who have sex with men with human immunodeficiency virus-1 infection between 2010 and 2020 in Japan: A single-center retrospective cohort study.

  2022cites this paper
• Modelling the contribution of incarceration and public health oriented drug law reform to HCV transmission and elimination among PWID in Tijuana, Mexico.

  2022cites this paper
• National Hepatitis C estimates: Incidence, prevalence, undiagnosed proportion and treatment, Canada, 2019

  2022cites this paper
• Mathematical modeling of HIV-HCV co-infection model: Impact of parameters on reproduction number [version 1; peer review: awaiting peer review]

  2022cites this paper
• Chronic Viral Hepatitis in Elite Athletes: Approaches to Risk Assessment, Prevention and Management

  2022cites this paper
• Mathematical modeling of HIV-HCV co-infection model: Impact of parameters on reproduction number

  2022cites this paper
• Liver‐related complications before and after successful treatment of chronic hepatitis C virus infection in people with inherited bleeding disorders

  2022cites this paper
• Prison‐based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling study

  2022cites this paper
• The Neutralizing Antibody Responses of Individuals That Spontaneously Resolve Hepatitis C Virus Infection

  2022cites this paper
• 17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon

  2022influential citation
• The Role of Sex in Acute and Chronic Liver Damage

  2022cites this paper
• Implementation of a controlled human infection model for evaluation of HCV vaccine candidates

  2022cites this paper
• Cost-effectiveness of hepatitis C virus (HCV) elimination strategies among people who inject drugs (PWID) in Tijuana, Mexico.

  2021cites this paper
• Incidence of Hepatitis C Virus Infections Among Users of Human Immunodeficiency Virus Pre-Exposure Prophylaxis.

  2021cites this paper
• A Multiancestry Sex-Stratified Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus

  2021cites this paper
• Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies

  2021cites this paper
• Role of interferon gamma gene polymorphism in spontaneous viral clearance versus chronicity in hepatitis C infected Egyptian patients

  2021cites this paper
• ASSOCIATION OF BODY MASS INDEX AND LIPID PROFILE WITH CHRONIC HEPATITIS C INFECTION

  2021cites this paper
• Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling study

  2021cites this paper
• Hepatitis C

  2021cites this paper
• Evaluating the impact and cost-effectiveness of scaling-up HCV treatment among people who inject drugs in Ukraine

  2021cites this paper
• Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV

  2021cites this paper
• Epidemiologic profile of hepatitis C virus infection and genotype distribution in Burkina Faso: a systematic review with meta-analysis

  2021cites this paper
• HIV and Hepatitis C in Corrections: A Public Health Opportunity

  2021cites this paper